VPC-13789
Product Specifications
CAS Number
2761146-51-2
Target
Others, Androgen Receptor
Related Pathways
Endocrinology/Hormones, Others
Bioactivity
VPC-13789 is a highly potent, selective, and orally bioavailable antiandrogen compound that shows promise for studying and developing therapeutics for castration-resistant prostate cancer (CRPC) . In LNCaP cells, VPC-13789 effectively inhibits the transcriptional activity of the androgen receptor (AR) with an IC50 value of 0.19 μM [1].
Smiles
FC1=C2C(C(=CN2)C3=NC4=C(C=C3)C(C(NC(C)C)=O)=CC=C4)=CC(F)=C1F
Molecular Formula
C21H16F3N3O
Molecular Weight
383.37
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP62545_P050-FITC 100 µL
FAHD2A Antibody - N-terminal region : FITC (ARP62545_P050-FITC)
Sign In for Pricing
View Details 
AP71088-01 20 µg
Recombinant Rat Type III iodothyronine deiodinase(Dio3), partial
Sign In for Pricing
View Details AP71088-02 100 µg
Recombinant Rat Type III iodothyronine deiodinase(Dio3), partial
Sign In for Pricing
View Details AP71088-03 1 mg
Recombinant Rat Type III iodothyronine deiodinase(Dio3), partial
Sign In for Pricing
View Details